MMJ Recs

MAY 5, 2024

Per California law, patients must meet a set of certain requirements to become eligible to obtain and use marijuana legally with a doctor’s recommendation. However, recreational use has also recently been legalized in California but it remains illegal under federal law.

Law 52

Law Marijuana Cultivation Patients 52

Cannabis Law Report

JANUARY 24, 2019

California established the Medical Marijuana Program (MMP) through Senate Bill 420 (Vasconcellos, 2003) which increased access to medical cannabis for qualifed patients and primary caregivers and provided protections from prosecution for the possession and cultivation of medical cannabis.

Safety 65

Safety Environment Cultivation Retail 65

Cannabis Law Report

SEPTEMBER 24, 2021

A series of events for industry and the public will be either hybrid (online and in-person) or online only, to allow more accessibility and ensure the comfort and safety of attendees. About Global Biotech Week: Originating in Canada in 2003, Biotech Week is now recognized around the world as Global Biotech Week. Jackie Robin.

Agriculture 52

Agriculture Research and Development Events Food 52

Cannabis Law Report

MAY 26, 2022

Instead, adult-use dispensaries in the state are proving the system works by checking IDs as required by state law. was published in the Journal of Safety Research and made available online on May 18. Journal of Safety Research. In addition, the effectiveness of MLDA-21 laws depends on enforcement. 2007, Shults et al.,

Dispensary 52

Dispensary Research and Development Safety Recreational 52

Cannabis Law Report

MAY 1, 2019

PUBLISHER: CANNABIS LAW REPORT. In February of this year, the California Bureau of Cannabis Control (“CBCC”) sent a letter to Weedmaps.com alleging that the website was “engaging in activity that violates state cannabis laws.” If nature abhors a vacuum, Congress abhors any space not yet filled with federal laws. John McKay.

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

APRIL 8, 2022

The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

JULY 8, 2021

According to KFOR, the bureau’s director, Donnie Anderson, has raised concerns about “international drug organizations and cartels moving into Oklahoma to take advantage of medical marijuana laws.”. Senator since 2003 and prior to that a member of the House of Representatives for seven years, “requested a direct appropriation through the U.S.

Programs 52

Programs Policy Cannabis Collective 52